Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients withAcute Respiratory Failure

Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients withAcute Respiratory Failure. All treated patients were in Intensive Care Units (ICU) on ventilators and sufferedfrom Acute Respiratory Distress Syndrome(ARDS). 100% survival rate for all seven patients.…










